512
Views
0
CrossRef citations to date
0
Altmetric
OPEN PEER COMMENTARIES

Beyond Autism: Advocacy for Neurodevelopmental Differences

ORCID Icon

REFERENCES

  • Beauchamp, T. L., and J. F. Childress. 2008. Principles of biomedical ethics, 6th ed. New York, NY; Oxford, UK: Oxford University Press.
  • Buescher, A. V. S., Z. Cidav, M. Knapp, and D. S. Mandell. 2014. Costs of autism spectrum disorders in the United Kingdom and the United States. Journal of American Medical Association Pediatrics 168(8): 721–728. [Published online]. doi: 10.1001/jamapediatrics.2014.210.
  • Graf, W. D. 2019. Deconstructing the autism concept and its semantics. Developmental Medicine & Child Neurology 61(9): 994. doi: 10.1111/dmcn.14312.
  • Graf, W. D., M. V. Kekatpure, and B. E. Kosofsky. 2013. Prenatal-onset neurodevelopmental disorders secondary to toxins, nutritional deficiencies, and maternal illness. Handbook of Clinical Neurology 111: 143–159. doi: 10.1016/B978-0-444-52891-9.00014-2.
  • Graf, W. D., G. Miller, L. G. Epstein, and I. Rapin. 2017. The autism “epidemic”: Ethical, legal, and social issues in a developmental spectrum disorder. Neurology 88(14): 1371–1380. doi: 10.1212/WNL.0000000000003791.
  • Leigh, J. P., and J. Du. 2015. Brief report: Forecasting the economic burden of autism in 2015 and 2025 in the United States. Journal of Autism and Developmental Disorders 45(12): 4135–4139. doi: 10.1007/s10803-015-2521-7.
  • Lord, C., S. Bishop, and D. Anderson. 2015. Developmental trajectories as autism phenotypes. American Journal of Medical Genetics Part C: Seminars in Medical Genetics 169(2): 198–208. doi: 10.1002/ajmg.c.31440.
  • McCoy, M., E. Y. Liu, A. S. F. Lutz, and D. Sisti. 2020. Ethical advocacy across the autism spectrum: Beyond partial representation. The American Journal of Bioethics 20(4): 13–24.
  • Sarrett, J. C. 2016. Biocertification and neurodiversity: The role and implications of self-diagnosis in autistic communities. Neuroethics 9(1): 23–36. doi: 10.1007/s12152-016-9247-x.
  • Srivastava, S., J. A. Love-Nichols, K. A. Dies, et al. 2019. Meta-analysis and multidisciplinary consensus statement: Exome sequencing is a first-tier clinical diagnostic test for individuals with neurodevelopmental disorders. Genetics in Medicine 21(11): 2413–2421. doi: 10.1038/s41436-019-0554-6.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.